A recent re-evaluation study reported that soluble APP-α and APP-β in CSF are strongly correlated with phosphorylated tau and are potentially useful biomarkers for earlier diagnosis of dementia disorders.
In his latest column, David Howett reviews a recent paper from Gunn-Moore et al. on the relationship between Alzheimer’s disease and Type 2 diabetes.
Read the third and final installment of our debate, which looks ahead at future research trends and the potential for personalized medicine.
Read the second installment of our Alzheimer’s genetics debate, with this part focusing on current research priorities, challenges and ethical concerns.
In the first installment of this debate, our experts discuss the contribution of genetics to Alzheimer’s risk, the differences between early- and late-onset disease, and how new technologies have advanced our understanding of this ever-expanding field.
Environmental change, and a growing and more connected population will promote vector-borne disease risk further. In this opinion piece, the authors discuss the role of climate modeling in disease prediction and epidemiology.
Tom Naughton introduces the circuitry underlying Parkinson’s disease, and how our understanding and new techniques have advanced hand-in-hand to bring us to where we are now.
Lauren Pulling, Editor, explores the longest-running lifetime cohort study in the world, including the new neuroscience clinical sub-study, Insight 46.